chr22-28695049-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007194.4(CHEK2):​c.1375+78C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.641 in 860,542 control chromosomes in the GnomAD database, including 178,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 28239 hom., cov: 32)
Exomes 𝑓: 0.65 ( 150544 hom. )

Consequence

CHEK2
NM_007194.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.158

Publications

12 publications found
Variant links:
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
CHEK2 Gene-Disease associations (from GenCC):
  • CHEK2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • Li-Fraumeni syndrome 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 22-28695049-G-C is Benign according to our data. Variant chr22-28695049-G-C is described in ClinVar as Benign. ClinVar VariationId is 1254473.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHEK2NM_007194.4 linkc.1375+78C>G intron_variant Intron 12 of 14 ENST00000404276.6 NP_009125.1 O96017-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHEK2ENST00000404276.6 linkc.1375+78C>G intron_variant Intron 12 of 14 1 NM_007194.4 ENSP00000385747.1 O96017-1

Frequencies

GnomAD3 genomes
AF:
0.606
AC:
92012
AN:
151944
Hom.:
28229
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.508
Gnomad AMI
AF:
0.684
Gnomad AMR
AF:
0.583
Gnomad ASJ
AF:
0.716
Gnomad EAS
AF:
0.634
Gnomad SAS
AF:
0.749
Gnomad FIN
AF:
0.650
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.643
Gnomad OTH
AF:
0.634
GnomAD4 exome
AF:
0.649
AC:
459918
AN:
708480
Hom.:
150544
AF XY:
0.655
AC XY:
246694
AN XY:
376848
show subpopulations
African (AFR)
AF:
0.513
AC:
9757
AN:
19024
American (AMR)
AF:
0.632
AC:
24696
AN:
39060
Ashkenazi Jewish (ASJ)
AF:
0.714
AC:
14747
AN:
20658
East Asian (EAS)
AF:
0.695
AC:
24389
AN:
35106
South Asian (SAS)
AF:
0.736
AC:
50116
AN:
68064
European-Finnish (FIN)
AF:
0.663
AC:
33182
AN:
50028
Middle Eastern (MID)
AF:
0.676
AC:
2740
AN:
4054
European-Non Finnish (NFE)
AF:
0.636
AC:
278186
AN:
437644
Other (OTH)
AF:
0.634
AC:
22105
AN:
34842
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8359
16719
25078
33438
41797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3644
7288
10932
14576
18220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.605
AC:
92049
AN:
152062
Hom.:
28239
Cov.:
32
AF XY:
0.606
AC XY:
45042
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.507
AC:
21048
AN:
41474
American (AMR)
AF:
0.583
AC:
8903
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.716
AC:
2485
AN:
3472
East Asian (EAS)
AF:
0.635
AC:
3278
AN:
5162
South Asian (SAS)
AF:
0.749
AC:
3609
AN:
4820
European-Finnish (FIN)
AF:
0.650
AC:
6857
AN:
10552
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.643
AC:
43710
AN:
67982
Other (OTH)
AF:
0.631
AC:
1334
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1841
3683
5524
7366
9207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.628
Hom.:
3755
Bravo
AF:
0.596
Asia WGS
AF:
0.723
AC:
2516
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
11
DANN
Benign
0.71
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5762749; hg19: chr22-29091037; COSMIC: COSV60415565; COSMIC: COSV60415565; API